Q3 2017 EPS Estimates for Orthofix International N.V. (OFIX) Increased by Analyst
Orthofix International N.V. (NASDAQ:OFIX) – Jefferies Group increased their Q3 2017 earnings per share estimates for Orthofix International N.V. in a research note issued on Monday. Jefferies Group analyst R. Denhoy now expects that the medical device company will post earnings per share of $0.45 for the quarter, up from their prior forecast of $0.43. Jefferies Group also issued estimates for Orthofix International N.V.’s Q4 2017 earnings at $0.42 EPS and FY2017 earnings at $1.57 EPS.
Several other analysts have also issued reports on OFIX. Zacks Investment Research upgraded shares of Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a research note on Thursday. BidaskClub lowered shares of Orthofix International N.V. from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Langenberg & Company reiterated a “buy” rating and issued a $53.25 target price on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. BTIG Research assumed coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 21st. They issued a “buy” rating and a $52.00 target price for the company. Finally, SunTrust Banks, Inc. assumed coverage on shares of Orthofix International N.V. in a research note on Tuesday, May 23rd. They issued a “buy” rating and a $49.00 target price for the company. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $52.30.
COPYRIGHT VIOLATION NOTICE: This news story was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/10/q3-2017-eps-estimates-for-orthofix-international-n-v-ofix-increased-by-analyst.html.
Shares of Orthofix International N.V. (OFIX) opened at 47.35 on Thursday. Orthofix International N.V. has a 52 week low of $32.51 and a 52 week high of $49.60. The firm’s market cap is $854.38 million. The firm has a 50-day moving average of $45.59 and a 200-day moving average of $40.76.
Orthofix International N.V. (NASDAQ:OFIX) last announced its quarterly earnings results on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. The firm had revenue of $108.90 million during the quarter, compared to analysts’ expectations of $102.94 million. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.41 earnings per share.
Several hedge funds have recently bought and sold shares of OFIX. State of Alaska Department of Revenue raised its stake in Orthofix International N.V. by 79.3% in the second quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock valued at $165,000 after buying an additional 1,571 shares during the last quarter. Mason Street Advisors LLC purchased a new stake in Orthofix International N.V. during the first quarter valued at about $159,000. Municipal Employees Retirement System of Michigan purchased a new stake in Orthofix International N.V. during the second quarter valued at about $196,000. Quantbot Technologies LP purchased a new stake in Orthofix International N.V. during the first quarter valued at about $175,000. Finally, BNP Paribas Arbitrage SA increased its position in shares of Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after buying an additional 1,900 shares during the period. Hedge funds and other institutional investors own 99.68% of the company’s stock.
Orthofix International N.V. Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.